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Background: Canine herpesvirus-1 (CHV1) causes a fatal hemorrhagic disease in neonatal puppies and is associated
with infertility in female dogs. This study was conducted to assess the status of CHV1 infection in bitches in proestrus
or estrus and to investigate possible risk factors by a detailed questionnaire. Blood samples were collected from healthy
bitches (n = 193) not vaccinated against CHV1, aged one year or older and admitted for estrus control to the Canine
Reproductive Clinical Unit, Norwegian School of Veterinary Science. The serum samples were analysed by immunoper-
oxidase monolayer assay and serum titers were recorded as the reciprocal value of the highest dilution producing
specific cell staining.
Results: Altogether, 85.5% of the dogs had CHV1 titers≥ 80 and were classified as positive. Mean age for dogs
included in the study was 4.2 years (95% CI 4.0-4.5), and there was no difference in age between seronegative dogs vs
seropositive dogs. When grouping the seropositive dogs into three categories according to the magnitude of the titer,
a total of 38.8% of the bitches displayed a weakly positive titer of 80, 44.8% had moderately positive titers of 160 or 320
and 16.4% of the dogs fell into the strongly positive category with titer of ≥640. No association was demonstrated
when comparing CHV1 antibody titers to fertility parameters such as previous matings, pregnancies, whelpings,
puppies born or condition of puppies. Further, there was no difference in seroprevalence between bitches that had
been abroad for a period of time and dogs only living within a Norwegian environment. Samples from dogs collected
in summer and fall displayed moderate to high antibody titers indicating recent infection with CHV1. Season, previous
birth, and participation in competitions/shows explained 67-78% of the variation in antibody titer.
Conclusions: This study demonstrates that CHV1 infection is common in breeding bitches in the eastern part of
Norway. Associations with putative risk factors were not identified. However, season, previous whelping, and
participation in competitions/shows explained 67-78% of the variation in antibody titer.
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There has been an increasing concern among dog breeders
in Norway about canine herpesvirus-1 (CHV1) and its
ability to cause reproductive problems in the bitch and
perinatal puppy loss [1]. Several studies report high sero-
prevalence in the dog population in many European coun-
tries and there is increased movement of dogs between
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reproduction in any medium, provided the orCHV1 is an alphaherpesvirus which was first reported
from the USA in the early 1960s [2]. In neonatal
puppies, the virus can produce a systemic fatal haemor-
rhagic infection causing focal necrosis in parenchymat-
ous organs of puppies up to 2-weeks-old [3,4]. CHV1 is
of low pathogenicity in puppies older than 5 weeks [5].
In the adult dog, the infection is usually asymptomatic,
but may cause upper respiratory infection [3] and ocular
disease [6,7]. However, in the bitch herpesvirus infection
has been associated with reproductive problems, such as
low conception rate, fetal resorption, abortion, stillborn
or weak puppies and small litter size both in experimen-
tal [8,9] and epidemiological studies [10-12]. Oronasalral Ltd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly credited.
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tion, but genital and transplacental transmission may
also occur [8,13,14].
In a recent study from Norway, 80% of the dogs in the
general adult population were classified as seropositive
[15]. No difference was observed between genders, but a
significant geographical variation was demonstrated. In
other countries the reported prevalence of antibodies
against CHV1 varies from approximately 20% to 94% in
healthy dog populations [16-18]. Some studies have re-
ported the median antibody titer to be significantly higher
in dogs from kennels with reproductive problems than in
those from kennels without fertility disorders [10,19]. Dif-
ferent factors might influence the seroprevalence in popu-
lations such as age distribution, number of dogs in
kennels and households and hygienic conditions, but the
conclusions have been inconsistent [11,12,15,19,20].
The aim of this study was to estimate the seropreva-
lence of CHV1 antibodies in reproductively active
bitches and to investigate possible risk factors.
Material and methods
Study design, animals and sampling
A cross-sectional study design was applied in this inves-
tigation. A total of 193 purebred bitches admitted for
routine estrus control to the Canine Reproductive
Clinical Unit at the Norwegian School of Veterinary
Science were included in the study. All were healthy,
one year of age or older (up to 9-years-old) and had not
been vaccinated against herpesvirus infection. The dogs
came from eastern Norway. All dog breeds were accepted
for sampling and 66 different breeds are represented in
this material. Of the 193 blood samples, 89 samples were
collected during winter (December–February), 74 during
spring (March–May), 20 during summer (June–August)
and 10 during fall (September–November). In total, 57.3%
of the bitches had been pregnant earlier, whereas the
remaining came for control before their first mating.
The study was conducted in agreement with the
provisions enforced by the Norwegian Animal Research
Authority (NARA).
The dog owners supplied information according to a
questionnaire including a number of putative risk factors
as last estrus, previous mating, whelping and the status
of puppies. Further, information about travelling abroad,
participation in dog shows, competitions and hunting
trials the last year were included (see Additional file 1).
The dog owners received information on the back-
ground and purpose of the study and gave their written
consent.
In the clinic, the routine procedure included ocular in-
spection of vulva, examination of vaginal smears to
evaluate cells from vagina and progesterone analysis of
serum to estimate ovulation time and optimal time formating or artificial insemination. In addition, blood sam-
ples were taken for analysis of antibodies against CHV1.
These blood samples were allowed to clot at room
temperature for 1–3 hours before centrifugation at
3000 rpm for 10 minutes. The serum fraction was care-
fully harvested and kept at −20°C until analysis.
Immunoperoxidase monolayer assay (IPMA)
The IPMA for demonstrating antibodies to CHV1 was
performed as described [15] and previously used both in
epidemiological [10,15] and prospective [21] studies.
IPMA is a virus neutralisation test. Briefly, monolayers
of CHV infected Madin-Darby canine kidney cells in
96-well microtiter plates were incubated with twofold di-
lutions 1:10 to 1:1280 of test sera. Following washing
and incubation steps, secondary peroxidase-conjugated
rabbit anti-dog immunoglobulin G was added (DAKO,
Denmark), and subsequently the substrate 3-amino-
9-ethylcarbazole (Invitrogen AB, Sweden). Positive and
negative serum samples were included. Serum titers
were recorded as the reciprocal value of the highest dilu-
tion producing specific cell staining. Titers equal to or
above 80 were considered positive for exposure to
CHV1. Further, increasing antibody titers were catego-
rized as; 80 = weakly positive, 160 and 320 =moderately
positive, 640 ≥ strongly positive.
The validation of the IPMA showed a sensitivity of
about 90% compared to an in-house ELISA test (National
Veterinary Institute, Sweden) used in a vaccine trial on
sera from dogs vaccinated against CHV. Twenty-seven
serum samples were collected from 13 dogs at intervals
during the trial. Estimation of the specificity is not
available.
Statistical analyses
Categorical variables are given in simple contingency
tables with numbers and percentages. Continuously
distributed variables are expressed as mean values
with 95% confidence intervals. All comparisons between
groups were performed two-tailed and differences con-
sidered significant at a level of 5%.
Contingency Table Analysis was first performed for
comparison of groups with regard to categorical vari-
ables [22]. For comparison of assumed continuously dis-
tributed variables, Analysis of Variance (ANOVA) was
used [23]. The variables which in the single analysis indi-
cated differences between positive and negative titers
were included in a forward and backward stepwise logis-
tic regression model [24]. The CHV1 titer categories were
used as the dependant variables. The set of independent
variables contributing to discriminate against negative
titer were season, previous birth and participation in com-
petitions. This set was included in the final logistic regres-
sion analysis. Reciever Operating Characteristics (ROC)
Table 1 Variables within positive vs negative titer
categories
Variables Outcome Titer category p-values
Negative Positive
Previous pregnancy No 10 72
Yes 18 92 0.61
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classification. The accuracy is said to be good if the area
under the ROC-curve (Auc) is larger than 0.7. An area
close to 0.5 represents no difference against negative titer.
The logistic model was evaluated using the Hosmer-
Lemeshow test and ROC analysis [25].Missing 0 1
Previous whelping No 14 83





Weak 0 1 0.83
Some dead 4 18
Missing 0 3
Previous unsuccessful
attempt to get pregnant
No 21 122
Yes 7 40 0.62
Missing 0 3
Stay abroad last year No 10 70





Yes 28 141 0.017
Missing 0 6Results
No pathological conditions were found during the clin-
ical examination and none of the dogs received any kind
of medical treatment at that time. During the last year,
only one dog had been treated to end a previous estrus
and none of the dogs had received long-lasting cortisone
treatment. Altogether 85.5% of the dogs had CHV1 anti-
body titers ≥ 80 and were classified as positive. Mean age
for dogs included in the study was 4.2 years (95% CI
4.0-4.5), and there was no difference in age between the
groups of seronegative dogs vs seropositive dogs. Fur-
ther, there were no significant differences in titer cat-
egories between dogs aged one, two and up to nine years
old. No association was demonstrated when comparing
CHV1 antibody titers and fertility parameters such as
previous matings, pregnancies or whelpings. Further-
more, no difference was observed between negative and
positive dogs with respect to information on the condi-
tion of puppies born previously (Table 1).
All of the bitches with negative titers had participated
in dog shows and competitions, whereas 11.3% of
the positive bitches had never attended such activities
(P = 0.017). There was no association between antibody
titer and travel abroad (Table 1).
Of all positive dogs, 38.8% displayed a titer of 80,
whereas 44.8% and 16.4% of the dogs fell into the mod-
erately and strongly positive categories, respectively
(Table 2). There was no difference in age between the
different titer categories. Further, there were no signifi-
cant differences between the different titer categories
with respect to previous matings, pregnancies and
whelpings or conditions of puppies born. However,
though not significant different, 11 of 27 (40.7%) dog
owners in the highest titer category reported problems
with getting the bitches pregnant after mating compared
to 7 of 28 (25.0%) of the negative dogs and 29 of 135
(21.5%, 3 missing observations) in the weakly and mod-
erately positive titer categories (Table 2). Travel abroad
had no influence on titer value, whereas significantly
fewer dogs within all positive titer categories had partici-
pated in dog shows, competitions or hunting trials com-
pared to dogs with negative titers (P = 0.01, Table 2).
Samples from all the negative dogs were collected during
winter and spring. Of the positive dogs, 81.8% (n = 135)
samples were collected during these two seasons. During
summer and fall, only bitches from the two highest titercategories were represented (P < 0.01, Table 3). By multi-
variable analysis, it was shown that each of the parame-
ters season, previous whelping, and participation in
competitions/shows contributed significantly (67-78%)
to the different antibody titer categories (Figure 1).Discussion
This study shows that the majority of clinically healthy
bitches presented to the Canine Reproductive Clinical
Unit at the Norwegian School of Veterinary Science,
have been infected by CHV1.
In a previous Norwegian study including both genders,
we demonstrated significant geographical differences
ranging between 58.5% in eastern Norway and 98% in
mid-Norway [15]. When comparing the seroprevalence
in the two dog populations originating from eastern
Norway and collected in the same period, there is a dif-
ference of 85.5% (breeding bitches in this study) vs
58.5% (dogs of both genders in the previous study). This
finding might indicate that reproductively active bitches
admitted to the reproduction clinic have a greater risk of
CHV1 exposure and subsequent infection compared to
the general dog population in this part of the country.
All bitches in the present study were in proestrus or
estrus. Although clear evidence of an association
Table 2 Variables within the three positive vs negative titer categories
Outcome Titer categories p-values
Negative Weaklya positive Moderatelyb positive Stronglyc positive
Previous pregnancy No 10 33 29 10
Yes 18 31 44 17 0.53
Missing 0 0 1 0
Previous whelping No 14 37 33 13
Yes 14 26 40 14 0.68
Missing 0 1 1 0
Condition puppies born previously Normal 10 20 30 10
Weak 0 1 0 0 0.78
Some dead 4 5 10 3
Missing 0 0 0 1
Previous unsuccessful attempt
to get pregnant
No 21 51 55 16
Yes 7 12 17 11 0.34
Missing 0 1 2 0
Stay abroad last year No 10 28 30 12
Yes 18 36 41 13 0.24
Missing 0 0 3 2
Participation in competitions last year No 0 5 11 2
Yes 28 59 59 23 0.01
Missing 0 0 4 2
aWeakly positive = 80.
bModerately positive = 160 and 320.
cStrongly positive ≥ 640.
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tions and viral activation have not been demonstrated,
Ronsse et al. [12] reported fluctuations in CHV1 anti-
body titers related to cycle stage. They found slightly
higher titers in estrus and significantly lower titers in
early di-estrus [11]. Both 17-β estradiol and medroxy-
progesterone acetate have been shown to promote her-
pes simplex virus type 1 reactivation in mice [26,27].
Evermann et al. [20] listed risk factors for reproductive
disease in the bitch, and cycle stage was identified as
one of 8 factors having a positive correlation withTable 3 Canine herpesvirus-1 serological classification in the
Titer Wintera Springb
No (%) No (%)
Negative 17 (8.8) 11 (5.7)
Weakly positive 37 (19.2) 27 (14.0)
Moderately positive 32 (16.6) 25 (13.0)
Strongly positive 3 (1.6) 11 (5.7)




dFall: September-November.disease. Whether estrus itself is a potential stressor
which can reactivate a latent infection or increase sus-
ceptibility for a new infection remains to be seen. How-
ever, clinical signs of reactivation have been described to
occur more frequently during heat and around partur-
ition [14]. Psychological stress has also been suggested
to contribute to reactivation of latent herpes simplex
virus in humans [28,29].
In Norway, few breeding dogs are kept in kennels, so
our data are not directly comparable to kenneled dogs in
studies from other countries. Babaei et al. [30] andtotal material (n = 193) by season of the year
Summerc Falld Total
No (%) No (%) No (%)
0 (0) 0 (0) 28 (14.5)
0 (0) 0 (0) 64 (33.2)
11 (5.7) 6 (3.1) 74 (38.3)
9 (4.7) 4 (2.1) 27 (14.0)
20 (10.4) 10 (5.2) 193 (100)
Figure 1 Receiver Operating Characteristic (ROC) including
season, previous birth and competitions/shows. Weakly positive
(green line) results in an area of 0.67, moderately positive (blue line)
0.74 and strongly positive (orange line) 0.78. The accuracy is said to
be good if the area under the ROCcurve (Auc) is larger than 0.7. An
area close to 0.5 represents no difference against negative titer.
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CHV1 seroprevalence between privately owned in-
house pets and kennelled dogs. Nöthling et al. [19] ob-
served that seroprevalence was independent of kennel
size, whereas Ronsse et al. [11] found higher titers in
kennels with 6–30 dogs than in those with fewer dogs.
There was no difference in age between the seronega-
tive and the seropositive bitches, and the seroprevalence
did not increase with age. This is in contrast to our pre-
vious study [15] and can be explained by less variation
in age in the breeding bitches in this study compared to
dogs in the general population.
In the current study, there were no significant correla-
tions between titer category and breeding status, such as
previous matings, previous whelping, failing to get the
bitch pregnant or conditions of puppies. This is in ac-
cordance with Ronsse et al. [18]. In the present study,
the time between previous mating and sampling is vari-
able, and the titer at previous mating is unknown. But,
interestingly, owners reported increasing problems of
getting the bitches pregnant after previous mating in the
highest titer category compared to the others. Recent
CHV1 infection coinciding with early stage of pregnancy
may result in fetal loss and this could be a plausible ex-
planation. Several authors have demonstrated an associ-
ation between CHV1 serological status and reproductive
problems. Dahlbom et al. [10] found that dogs from
kennels with reproductive problems had significantly
higher CHV1 titers than dogs from kennels withoutreproduction problems. Ronsse et al. [11] demonstrated
an association between serological status and a history
of abortion in bitches. Furthermore, Van Gucht et al.
[31] found a relation between the presence of positive
breeding bitches and neonatal death and/or infertility in
the kennel.
Travel abroad with breeding dogs is quite common in
Norway and is confirmed by dog-owners in this investi-
gation for both antibody positive and –negative dogs.
However, travel abroad had no influence on the titer
values. This was also the fact when this was tested as a
separate risk factor in our previous study of dogs in dif-
ferent parts of Norway [15]. By multivariable analysis, it
was shown that the variable travel abroad contributed to
a better classification of seropositive dogs in our previ-
ous study, which was not the case in this study with
fewer dogs included. Surprisingly, significantly fewer
dogs within all positive titer categories had participated
in dog shows, competitions or hunting trials compared
to dogs with negative titers. This might be related to the
fact that the owners of the bitches in this study are com-
mitted, well-informed breeders and even though they
travel or participate in different competitions, they keep
their dogs under more controlled conditions than dog
owners in general. The attitude and behavior of the
owners in addition to the very low number of dogs not
participating in competitions, might therefore be pos-
sible confounders in this study. We can conclude that the
endemic status of CHV1 infection in the Norwegian
dog population provides ample opportunities for spread of
the virus. Staying abroad or participation in competitions/
shows does not seem to add an extra risk of contracting
infection in this study.
In our data, 57.3% of the dogs had been pregnant prior
to sampling. No difference in seroprevalence between
this group of bitches and those being mated for the first
time was demonstrated, indicating that the oronasal in-
fection route is the most likely way of virus transmission
between dogs. This finding is in accordance with other
studies [12,15,18] of adult dog populations. However,
Babaei et al. [30], suggest that oronasal transmission of
CHV1 may be epidemiologically less important than
venereal transmission. In their study, no seropositive
dog was detected in animals younger than 12 months of
age. It might be important to emphasize that the overall
CHV1 seroprevalence was estimated to 20.7%, which is
very low.
In spite of the high seroprevalence in reproductively
active dogs, we have the opinion that fertility problems
and loss of newborn puppies due to CHV1 infection at
present are of minor importance in Norway. There are
no epidemiological data available regarding the preva-
lence of reproduction disorders in bitches. However, two
recent studies on postnatal puppy mortality have been
Krogenæs et al. Acta Veterinaria Scandinavica 2014, 56:19 Page 6 of 7
http://www.actavetscand.com/content/56/1/19published. Indrebø et al. [32] reported a total puppy loss
to be 6.9% during the first three weeks of life in a se-
lected population of four breeds. Etiological diagnosis
was not recorded, and the authors concluded that im-
pact of CHV1 infection was unlikely because of rare oc-
currence and no evidence indicating this disease.
Tønnessen et al. [33] reported perinatal mortality in a
large-scale observational study including 10.810 litters
and 224 breeds. In total, perinatal mortality was ob-
served in 8% of the puppies (4.3% stillborn and 3.7%
died before age of 8 days). Autopsy was not performed
and causes for perinatal mortality not pursued. Obvi-
ously, there is need for follow-up investigations to find
etiological causes of these clinical manifestations. At
the Norwegian Veterinary Institute in Oslo, CHV1 has
been diagnosed sporadically in newborn puppies (Øyvor
Kolbjørnsen, personal communication). There is most
likely an underdiagnosing of CHV1 infection because
few puppies are submitted for autopsy due to high costs.
In Norway, dogs are kept in households usually includ-
ing one family dog, occasionally two, and there are few
big breeding kennels [34]. Management and hygienic
conditions are generally good and the stress level low
probably contributing to less impact of CHV1. The fact
that most bitches are seropositive to CHV1 following
natural immunization, may protect the puppies against
disease. Further, satisfactory vaccine coverage against
other diseases, provide fetuses and puppies with good
general protection against infection.
Interestingly, moderately positive and highly positive
bitches were found only in dogs sampled during summer
and fall, whereas no negative or weakly positive dogs
were sampled in these seasons. This might indicate that
the dogs are more exposed to new infections or re-
expression of latent infections during the summer and
fall, which could be due to increased outdoor activities
in general and contact with other dogs in this period.
Our findings may explain observations by Tønnessen
et al. [33] that litters born during fall had a higher risk
of experiencing early neonatal mortality than litters born
during other seasons.
The three parameters of season, previous birth and
participation in competitions/shows increase the prob-
ability of correct classification between the different titer
categories to between 70 to 80%.
Vaccination against CHV1 infection is used in some
countries. In Norway, the herpesvirus vaccine is a non-
core vaccine. Vaccination is not routinely recommended
for breeding bitches. Nevertheless, veterinarians experi-
ence an increased demand for vaccination from owners
concerned about CHV1 infection and impact of their
breeding success. In case of an increased risk of CHV1
infection by recent contact with other bitches that have
aborted, borne weak puppies or suffered increasedneonatal mortality due to CHV1, vaccination should be
considered in young females entering into their first or
second pregnancy. In bitches with a positive CHV1 anti-
body titer from natural infection, protective efficacy is
difficult to evaluate. We consider the status of majority
of these dogs as being protected. Moreover, if reactiva-
tion of virus occurs, this is likely to boost the immune
response and increase level of immunity. However, there
might be relevant to consider vaccination even though
naturally acquired antibodies are present, for example in
older breeding bitches from about six years age. Here a
reactivation may be more likely to cause problems since
aging is associated with decreased immune responsive-
ness and increased susceptibility to infectious diseases
[20,35,36].
Conclusions
This study demonstrates that CHV1 infection is common
in reproductively active bitches. There is no correlation
between high seroprevalences and previously reported re-
productive disorders in connection to matings, pregnan-
cies, whelpings or mortality in newborn puppies in the
bitches’ life. Travelling abroad the last year did not influ-
ence antibody titer. All of the negative bitches, but only
81.8% of the positive bitches had participated in competi-
tions/shows the last year, which indicates that in this data,
these activities were not related to increased risk of her-
pesvirus infection. By multivariable analysis, it was shown
that each of the parameters season, previous birth, and
participation in competitions/shows explained 67-78% of
the variation in antibody titer.
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